Page 56 - Study Results News Today

Aktien: Curevac bestätigt geringe Wirksamkeit - Aktie bricht ein Anzeige / Werbung Die bereits in einer vorläufigen Analyse festgestellte geringe Wirksamkeit des Curevac-Impfstoffs hat sich auch in der Endauswertung bestätigt. Die Aktie tritt den Rückzug an. In der finalen Curevac-Studie zeigte das Vakzin eine Wirksamkeit von 48 Prozent gegen eine Covid-Erkrankung jeglichen Schweregrades und in allen Altersgruppen, Bei einer Zwischenanalyse vor zwei Wochen waren es 47 Prozent gewesen. Hie...

EQS-Adhoc: Polyphor AG: Polyphor gibt Update zur Phase-III-Studie FORTRESS mit Balixafortide bei Patientinnen mit fortgeschrittenem HER2-negativem Brustkrebs Polyphor gibt Update zur Phase-III-Studie FORTRESS mit Balixafortide bei Patientinnen mit fortgeschrittenem HER2-negativem Brustkrebs 28.06.2021 / 07:00 CET/CEST Veröffentlichung einer Ad-hoc-Mitteilung gemäss Art. 53 KR Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Allschwil, Schweiz, 28. Juni 2021 Polyp...

In den USA hat sich die Ankündigung der Notenbank, die Zinsen 2023 anzupassen, positiv auf den Dollar-Kurs ausgewirkt. Nun will auch der Bundesbank-Chef ein Ende der Coronahilfen.

Kaum ein Land hat so große Teile seiner Bevölkerung gegen Corona geimpft wie Chile. Trotzdem verzeichnet es erneut rekordverdächtige Infektionszahlen. In der Hauptstadtregion gilt nun wieder die höchste Lockdown-Stufe.

STOCKHOLM, SWEDEN 1 June 2021. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that the portfolio company Dilafor has concluded a phase 2b study with its drug candidate tafoxiparin which showed a significant positive impact on cervical ripening in first-time mothers receiving treatment to induce labor. Further and full analysis of data will be done by the company. Market analyses show that a drug that can induce cervical ripening has the potential to reach annual sales in exce...

Full Story Evidence indicating that face masks can help control the spread of the novel coronavirus that causes COVID-19 has grown since the virus first emerged, upending life around the world. In March, we outlined the evolving research on the efficacy of face masks and explained why experts support their use. But a stubborn thread of misinformation falsely claiming that masks do not work, and are actually dangerous, continues to be recycled and shared a year-plus into the pandemic. Viral head...

Fact Check: Stories falsely cite Stanford study to misinform on face masks Share Updated: 11:14 PM CDT Apr 22, 2021 By Angelo Fichera, FactCheck.org Share Updated: 11:14 PM CDT Apr 22, 2021 Hide Transcript Show Transcript primary reason that you should wear a mask for anyone should wear a mask is because a mask or a face covering reduces the potential that you might infect someone else. And what were seeing with this disease is that in some reports, up to 60% ...

U.S. Passes 100 Million Doses; California Eases: Virus Update Bloomberg 3/12/2021 Bloomberg News © Bloomberg A healthcare worker administers a dose of the Moderna Covid-19 vaccine to a farmworker at a vaccination clinic organized by the Santa Clara County Public Health Department at Christopher Ranch in Gilroy, California, U.S., on Thursday, March 4, 2021. Farmworkers have been one of the hardest hit communities since the start of the pandemic. (Bloomberg) -- The U.S. passe...

U.S. Passes 100 Million Doses; California Eases: Virus Update Bloomberg 3/12/2021 Bloomberg News © Bloomberg A healthcare worker administers a dose of the Moderna Covid-19 vaccine to a farmworker at a vaccination clinic organized by the Santa Clara County Public Health Department at Christopher Ranch in Gilroy, California, U.S., on Thursday, March 4, 2021. Farmworkers have been one of the hardest hit communities since the start of the pandemic. (Bloomberg) -- The U.S. passe...

/PRNewswire/ -- The recent remote work trend caused by the pandemic has increased password security risks of both companies and individuals. Despite this fact,...